Federal Register / Vol. 78, No. 105 / Friday, May 31, 2013 / Notices 32657 

this system should follow the same 

instructions indicated under 

‘‘Notification Procedure.’’ The request 

should reasonably identify the record, 

specify the information contested, state 

the corrective action sought, and 

provide the reasons for the correction, 

with supporting justification. 

RECORD SOURCE CATEGORIES: 

All information will be collected 

directly from the individual applicants/ 

users of the Web site, when they 

complete the online application forms. 

EXEMPTIONS CLAIMED FOR THIS SYSTEM: 

None. 

Dated: May 21, 2013. 

Carolyn M. Clancy, 

AHRQ Director. 

[FR Doc. 2013–12671 Filed 5–30–13; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention (CDC) 

Board of Scientific Counselors, 

National Center for Environmental 

Health/Agency for Toxic Substances 

and Disease Registry (BSC, NCEH/ 

ATSDR) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Times and Dates: 8:30 a.m.–3:00 p.m., 

June 27, 2013; 8:30 a.m.–12:00 p.m., 

June 28, 2013. 

Place: CDC, 4770 Buford Highway, 

Atlanta, Georgia 30341. 

Status: Open to the public, limited 

only by the space available. The meeting 

room accommodates approximately 60 

people. 

Purpose: The Secretary, Department 

of Health and Human Services (HHS) 

and by delegation, the Director, CDC 

and Administrator, NCEH/ATSDR, are 

authorized under Section 301(42 U.S.C. 

241) and Section 311(42 U.S.C. 243) of 

the Public Health Service Act, as 

amended, to: (1) Conduct, encourage, 

cooperate with, and assist other 

appropriate public authorities, scientific 

institutions, and scientists in the 

conduct of research, investigations, 

experiments, demonstrations, and 

studies relating to the causes, diagnosis, 

treatment, control, and prevention of 

physical and mental diseases and other 

impairments; (2) assist states and their 

political subdivisions in the prevention 

of infectious diseases and other 

preventable conditions and in the 

promotion of health and well being; and 

(3) train state and local personnel in 

health work. The BSC, NCEH/ATSDR 

provides advice and guidance to the 

Secretary, HHS; the Director, CDC and 

Administrator, ATSDR; and the 

Director, NCEH/ATSDR, regarding 

program goals, objectives, strategies, and 

priorities in fulfillment of the agency’s 

mission to protect and promote people’s 

health. The board provides advice and 

guidance that will assist NCEH/ATSDR 

in ensuring scientific quality, 

timeliness, utility, and dissemination of 

results. The board also provides 

guidance to help NCEH/ATSDR work 

more efficiently and effectively with its 

various constituents and to fulfill its 

mission in protecting America’s health. 

Matters To Be Discussed: The agenda 

items for the BSC Meeting on June 27– 

28, 2013 will include NCEH/ATSDR 

Office of the Director updates: 

Environmental Health Emergencies 

updates, Lead Poisoning Prevention 

Activities updates, Epi Aids at NCEH/ 

ATSDR update, Strategic Planning 

updates; and updates by BSC Federal 

Expert members on current activities at 

the National Institute for Occupational 

Safety and Health, U.S. Department of 

Energy, National Institute for 

Environmental Health Services and the 

U.S. Environmental Protection Agency. 

Agenda items are subject to change as 

priorities dictate. 

SUPPLEMENTARY INFORMATION: The 

public comment period is scheduled on 

Thursday, June 27, 2013 from 2:30 p.m. 

until 2:45 p.m., and on Friday, June 28, 

2013 from 10:00 a.m. until 10:15 a.m. 

Contact Person for More Information: 

Sandra Malcom, Committee 

Management Specialist, NCEH/ATSDR, 

CDC, 4770 Buford Highway, Mail Stop 

F–61, Chamblee, Georgia 30345; 

telephone 770/488–0575 or 770/488– 

0755, Fax: 770/488–3377; Email: 

smalcom@cdc.gov. The deadline for 

notification of attendance is June 21, 

2013. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention (CDC). 

[FR Doc. 2013–12912 Filed 5–30–13; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–10302, CMS– 

R–290 and CMS–10437] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS), Department of Health 

and Human Services, is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the Agency’s function; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Collection 

Requirements for Compendia for 

Determination of Medically-accepted 

Indications for Off-label Uses of Drugs 

and Biologicals in an Anti-cancer 

Chemotherapeutic Regimen Use: 

Section 182(b) of the Medicare 

Improvement of Patients and Providers 

Act (MIPPA) amended section 

1861(t)(2)(B) of the Social Security Act 

(42 U.S.C. 1395x(t)(2)(B)) by adding at 

the end the following new sentence: ‘On 

and after January 1, 2010, no compendia 

may be included on the list of 

compendia under this subparagraph 

unless the compendia has a publicly 

transparent process for evaluating 

therapies and for identifying potential 

conflicts of interest.’ We believe that the 

implementation of this statutory 

provision that compendia have a 

‘‘publicly transparent process for 

evaluating therapies and for identifying 

potential conflicts of interests’’ is best 

accomplished by amending 42 CFR 

414.930 to include the MIPPA 

requirements and by defining the key 

components of publicly transparent 


tkelley on DSK3SPTVN1PROD with NOTICES
32658 Federal Register / Vol. 78, No. 105 / Friday, May 31, 2013 / Notices 

processes for evaluating therapies and 

for identifying potential conflicts of 

interests. 

All currently listed compendia will be 

required to comply with these 

provisions, as of January 1, 2010, to 

remain on the list of recognized 

compendia. In addition, any 

compendium that is the subject of a 

future request for inclusion on the list 

of recognized compendia will be 

required to comply with these 

provisions. No compendium can be on 

the list if it does not fully meet the 

standard described in section 

1861(t)(2)(B) of the Act, as revised by 

section 182(b) of the MIPPA. Form 

Number: CMS–10302 (OCN: 0938– 

1078); Frequency: Annually; Affected 

Public: Business and other for-profits 

and Not-for-profit institutions; Number 

of Respondents: 845; Total Annual 

Responses: 900; Total Annual Hours: 

5,135. (For policy questions regarding 

this collection contact Brijet Coachman 

at 410–786–7364. For all other issues 

call 410–786–1326.) 

2. Type of Information Collection 

Request: Reinstatement of a currently 

approved collection; Title: Medicare 

Program: Procedures for Making 

National Coverage Decisions; Use: We 

revised our April 27, 1999 (64 FR 

22619) notice and published a new 

notice on September 26, 2003 (68 FR 

55634) that described the process we 

use to make Medicare coverage 

decisions including decisions regarding 

whether new technology and services 

can be covered. We have made changes 

to our internal procedures in response 

to the comments we received following 

publication of the 1999 notice and 

experience under our new process. Over 

the past several years, we received 

numerous suggestions to further revise 

our process to continue to make it more 

open, responsive, and understandable to 

the public. We share the goal of 

increasing public participation in the 

development of Medicare coverage 

issues. This will assist us in obtaining 

the information we require to make a 

national coverage determination in a 

timely manner and ensuring that the 

Medicare program continues to meet the 

needs of its beneficiaries. Form Number: 

CMS–R–290 (OCN: 0938–0776); 

Frequency: Annual; Affected Public: 

Private sector: Business or other forprofits; Number of Respondents: 200; 

Total Annual Responses: 200; Total 

Annual Hours: 8,000. (For policy 

questions regarding this collection 

contact Katherine Tillman at 410–786– 

9252. For all other issues call 410–786– 

1326.) 

1. Type of Information Collection 

Request: New collection (Request for a 

new control number; Title of 

Information Collection: Generic Social 

Marketing & Consumer Testing 

Research; Use: The purpose of this 

submission is to request an Information 

Collection Request (ICR) generic 

clearance for a program of consumer 

research aimed at a broad audience of 

those affected by CMS programs 

including Medicare, Medicaid, 

Children’s Health Insurance Program 

(CHIP), and health insurance exchanges. 

This program extends strategic efforts to 

reach and tailor communications to 

beneficiaries, caregivers, providers, 

stakeholders, and any other audiences 

that would support the Agency in 

improving the functioning of the health 

care system, improve patient care and 

outcomes, and reduce costs without 

sacrificing quality of care. With the 

clearance, we will create a streamlined 

and proactive process for collection of 

data and utilizing the feedback on 

service delivery for continuous 

improvement of communication 

activities aimed at diverse CMS 

audiences. 

The generic clearance will allow rapid 

response to inform CMS initiatives 

using a mixture of qualitative and 

quantitative consumer research 

strategies (including formative research 

studies and methodological tests) to 

improve communication with key CMS 

audiences. As new information 

resources and persuasive technologies 

are developed, they can be tested and 

evaluated for beneficiary response to the 

materials and delivery channels. Results 

will inform communication 

development and information 

architecture as well as allow for 

continuous quality improvement. The 

overall goal is to maximize the extent to 

which consumers have access to useful 

sources of CMS program information in 

a form that can help them make the 

most of their benefits and options 

The activities under this clearance 

involve social marketing and consumer 

research using samples of self-selected 

customers, as well as convenience 

samples, and quota samples, with 

respondents selected either to cover a 

broad range of customers or to include 

specific characteristics related to certain 

products or services. All collection of 

information under this clearance will 

utilize a subset of items drawn from a 

core collection of customizable items 

referred to as the Social Marketing and 

Consumer Testing Item Bank. This item 

bank is designed to establish a set of 

pre-approved generic questions that can 

be drawn upon to allow for the rapid 

turn-around consumer testing required 

for us to communicate more effectively 

with our audiences. The questions in 

the item bank are divided into two 

major categories. One set focuses on 

characteristics of individuals and is 

intended primarily for participant 

screening and for use in structured 

quantitative on-line or telephone 

surveys. The other set is less structured 

and is designed for use in qualitative 

one-on-one and small group discussions 

or collecting information related to 

subjective impressions of test materials. 

A Study Initiation Request Form 

detailing each specific study 

(description, methodology, estimated 

burden) conducted under this clearance 

will be submitted before any testing is 

initialed. Results will be compiled and 

disseminated so that future 

communication can be informed by the 

testing results. We will use the findings 

to create the greatest possible public 

benefit. Form Number: CMS–10437 

(OCN: 0938-New); Frequency: Yearly; 

Affected Public: Individuals. Number of 

Respondents: 41,592. Number of 

Responses: 28,800. Total Annual Hours: 

21,488. (For policy questions regarding 

this collection contact Julie Franklin at 

410–786–8126. For all other issues call 

410–786–1326.) 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS Web site 

address at http://www.cms.hhs.gov/ 

PaperworkReductionActof1995, or 

Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office on (410) 786– 

1326. 

To be assured consideration, 

comments and recommendations for the 

proposed information collections must 

be received by the OMB desk officer at 

the address below, no later than 5 p.m. 

on July 1, 2013. 

OMB, Office of Information and 

Regulatory Affairs, Attention: CMS Desk 

Officer, Fax Number: (202) 395–6974, 

Email: OIRA_submission@omb.eop.gov. 

Dated: May 28, 2013. 

Martique Jones, 

Deputy Director, Regulations Development 

Group, Office of Strategic Operations and 

Regulatory Affairs. 

[FR Doc. 2013–12934 Filed 5–30–13; 8:45 am] 

BILLING CODE 4120–01–P 


tkelley on DSK3SPTVN1PROD with NOTICES